Rep. C. Scott Franklin Sells Kenvue Inc. (NYSE:KVUE) Shares

Posted by Defense World Staff on Jul 19th, 2025

Representative C. Scott Franklin (R-Florida) recently sold shares of Kenvue Inc. (NYSE:KVUE). In a filing disclosed on July 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on June 16th. The trade occurred in the Representative’s “FIDELITY JOINT TBE” account.

Representative C. Scott Franklin also recently made the following trade(s):

Sold $15,001 – $50,000 in shares of Visa (NYSE:V) on 6/16/2025.
Sold $15,001 – $50,000 in shares of Apple (NASDAQ:AAPL) on 6/16/2025.
Sold $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 6/16/2025.
Sold $1,001 – $15,000 in shares of Merck & Co., Inc. (NYSE:MRK) on 6/16/2025.
Sold $15,001 – $50,000 in shares of McDonald’s (NYSE:MCD) on 6/16/2025.
Sold $1,001 – $15,000 in shares of United Parcel Service (NYSE:UPS) on 6/16/2025.
Sold $15,001 – $50,000 in shares of Johnson & Johnson (NYSE:JNJ) on 6/16/2025.
Sold $15,001 – $50,000 in shares of Walmart (NYSE:WMT) on 6/16/2025.
Sold $15,001 – $50,000 in shares of Berkshire Hathaway (NYSE:BRK.B) on 6/16/2025.
Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 6/16/2025.

Kenvue Trading Up 0.7%

NYSE KVUE opened at $22.00 on Friday. The business has a 50 day simple moving average of $22.20 and a 200 day simple moving average of $22.30. Kenvue Inc. has a one year low of $17.85 and a one year high of $25.17. The stock has a market capitalization of $42.21 billion, a P/E ratio of 40.00, a P/E/G ratio of 3.41 and a beta of 0.83. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.86 and a quick ratio of 0.60.

Kenvue (NYSE:KVUE – Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.23 by $0.01. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The business had revenue of $3.74 billion during the quarter, compared to analysts’ expectations of $3.69 billion. During the same quarter last year, the firm posted $0.28 earnings per share. The firm’s revenue was down 3.9% on a year-over-year basis. Research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Barclays reduced their price objective on Kenvue from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday. Citigroup reduced their price objective on Kenvue from $24.50 to $22.00 and set a “neutral” rating for the company in a research note on Tuesday. Bank of America reduced their price objective on Kenvue from $27.00 to $25.00 and set a “buy” rating for the company in a research note on Tuesday. UBS Group reduced their price objective on Kenvue from $25.00 to $23.00 and set a “neutral” rating for the company in a research note on Thursday. Finally, Evercore ISI started coverage on Kenvue in a research note on Monday, March 24th. They issued an “in-line” rating and a $25.00 price objective for the company. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus price target of $24.71.

Get Our Latest Stock Analysis on KVUE

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Cambridge Investment Research Advisors Inc. lifted its holdings in Kenvue by 4.0% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 106,140 shares of the company’s stock worth $2,545,000 after acquiring an additional 4,034 shares during the period. Starboard Value LP bought a new stake in Kenvue during the fourth quarter worth $467,864,000. TrueMark Investments LLC lifted its holdings in Kenvue by 9.3% during the fourth quarter. TrueMark Investments LLC now owns 190,595 shares of the company’s stock worth $4,069,000 after acquiring an additional 16,161 shares during the period. Kingswood Wealth Advisors LLC bought a new stake in Kenvue during the first quarter worth $413,000. Finally, Cooper Investors PTY Ltd. lifted its holdings in Kenvue by 39.7% during the first quarter. Cooper Investors PTY Ltd. now owns 858,076 shares of the company’s stock worth $20,577,000 after acquiring an additional 244,043 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Representative Franklin

Scott Franklin (Republican Party) is a member of the U.S. House, representing Florida’s 18th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Franklin (Republican Party) is running for re-election to the U.S. House to represent Florida’s 18th Congressional District. He declared candidacy for the 2026 election.

Scott Franklin was born in Thomaston, Georgia. Franklin graduated from Lakeland High School. He served in the U.S. Navy from 1986 to 2000 and the U.S. Navy Reserve from 2000 to 2012.

Franklin earned a B.S. from the United States Naval Academy in 1986 and an M.B.A. from Embry-Riddle Aeronautical University in 1994. Franklin’s career experience includes owning an insurance agency and working as a naval aviator with the U.S. Navy.

About Kenvue

(Get Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.